US 11834649
CRISPR/CAS-related methods and compositions for treating herpes simplex virus
granted A61PA61P27/02A61P31/22
Quick answer
US patent 11834649 (CRISPR/CAS-related methods and compositions for treating herpes simplex virus) held by Editas Medicine, Inc. expires Mon Nov 30 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Editas Medicine, Inc.
- Grant date
- Tue Dec 05 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 30 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 21
- CPC classes
- A61P, A61P27/02, A61P31/22